The genetic marker HLA-B27 is found in a high percentage of patients with spondyloarthropathic disease (ankylosing spondylitis, Reiter's syndrome, and related disorders) but the underlying basis for this association is not known. The studies described in this proposal will investigate the relationship between HLA-B27 and disease. Two experimental approaches will be used, the combination of which should yield a high probability of determining whether the HLA-B27-associated disease susceptibility factor is the B27 molecule itself or an allele at another locus that exists in strong linkage disequilibrium with HLA-B27. A population of HLA-typed individuals will be studied, including B27+ and B27- normal controls, B27+ and B27- patients with spondyloarthropathies, control patients with other rheumatic diseases, and selected families. Peripheral blood lymphocytes from these individuals will be subjected to two fundamental lines of experimentation: (1) The cells will be assayed for susceptibility to lysis by a panel of human cytolytic T lymphocyte clones, each specific either for an epitope on the HLA-B27 molecule or for a control antigenic determinant. Correlations will be made within the study population between B27-associated, cytolytic T cell defined epitopes and the presence or absence of B27-associated spondyloarthropathic disease. These experiments will test the hypothesis that a T cell-defined HLA determinant is more closely associated with disease susceptibility than is serologically defined HLA-B27. (2) Genomic DNA extracted from the cells will be digested with restriction endonucleases; the resulting DNA fragments will be electrophoretically separated, blotted, and hybridized by the method of Southern with one or more 32p-DNA probes specific for base pair sequences of the HLA-B locus. Correlations will be made within the study population between the observed restriction fragment length polymorphism and the presence or absence of B27-associated disease. A genomic clone encoding the HLA-B27 antigen from a normal individual will be isolated. If a disease-associated DNA restriction fragment is identified, it will be subjected to molecular cloning and its structure will be compared with that of the cloned B27 gene.

National Institute of Health (NIH)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Research Project (R01)
Project #
Application #
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Texas Sw Medical Center Dallas
Schools of Medicine
United States
Zip Code
van Duivenvoorde, Leonie M; Dorris, Martha L; Satumtira, Nimman et al. (2012) Relationship between inflammation, bone destruction, and osteoproliferation in the HLA-B27/human ýý2 -microglobulin-transgenic rat model of spondylarthritis. Arthritis Rheum 64:3210-9
Taurog, Joel D; Rival, Claudia; van Duivenvoorde, Leonie M et al. (2012) Autoimmune epididymoorchitis is essential to the pathogenesis of male-specific spondylarthritis in HLA-B27-transgenic rats. Arthritis Rheum 64:2518-28
Taurog, Joel D; Dorris, Martha L; Satumtira, Nimman et al. (2009) Spondylarthritis in HLA-B27/human beta2-microglobulin-transgenic rats is not prevented by lack of CD8. Arthritis Rheum 60:1977-84
Fert, Ingrid; Glatigny, Simon; Poulain, Cecile et al. (2008) Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/HUMAN beta2-microglobulin-transgenic rat lines. Arthritis Rheum 58:3425-9
Tran, Tri M; Dorris, Martha L; Satumtira, Nimman et al. (2006) Additional human beta2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 54:1317-27
Turner, Matthew J; Sowders, Dawn P; DeLay, Monica L et al. (2005) HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 175:2438-48
Tran, Tri Minh; Satumtira, Nimman; Dorris, Martha L et al. (2004) HLA-B27 in transgenic rats forms disulfide-linked heavy chain oligomers and multimers that bind to the chaperone BiP. J Immunol 172:5110-9
May, Ekkehard; Dorris, Martha L; Satumtira, Nimman et al. (2003) CD8 alpha beta T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 170:1099-105
Krug, H E; Taurog, J D (2000) HLA-B27 has no effect on the phenotypic expression of progressive ankylosis in ank/ank mice. J Rheumatol 27:1257-9
Gur, H; Geppert, T D; Wacholtz, M C et al. (1999) The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction. Cell Immunol 191:105-16

Showing the most recent 10 out of 32 publications